Making wealth creation easy, accessible and transparent. Pfizer is laying off an undisclosed amount of employees after confirming it’s shutting down its New Jersey facility Two other facilities ...

Pfizer on Wednesday revealed that it raised ... But these rebates and discounts, which are currently not transparent, aren't always passed on from PBMs to insurers and other payers.

It will define the extent to which the EC must be transparent in its actions ... access to the conversations between von der Leyen and Pfizer's CEO, Albert Bourla, regarding vaccines.

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure ...

Current FDA approved weight loss meds Wegovy and Zepbound are weekly injections. Pfizer announced early Thursday morning that it has selected its preferred once-daily modified release formulation ...

Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral ...

Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...

They even generated clinical results that suggested it might have promise as a weight-loss drug as well — only to have Pfizer, which had agreed to fund the research, withdraw its support ...